Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MNK | Mallinckrodt Plc | -0.28% | 35.97 | 21.1% | $138.29m | |
| PRGO | Perrigo Co. Plc | -1.88% | 74.07 | 6.7% | $126.06m | |
| SHPG | Shire PLC Sponsored ADR | 0.46% | 171.43 | 0.4% | $113.20m | |
| ENDP | Endo International Plc | -1.95% | 15.60 | 8.9% | $89.97m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.16% | 173.97 | 2.2% | $72.74m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 3.50% | 107.00 | 18.7% | $69.26m | |
| SAGE | SAGE Therapeutics, Inc. | 3.81% | 153.87 | 9.6% | $58.93m | |
| UTHR | United Therapeutics Corporation | 2.46% | 128.11 | 14.4% | $52.33m | |
| CTLT | Catalent Inc | 0.70% | 41.58 | 2.6% | $48.31m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | 2.41% | 137.49 | 6.8% | $42.64m | |
| PTLA | Portola Pharmaceuticals, Inc. | 1.20% | 25.32 | 7.7% | $42.29m | |
| SUPN | Supernus Pharmaceuticals, Inc. | -0.11% | 44.35 | 6.2% | $40.49m | |
| ICLR | ICON Plc | 1.41% | 143.94 | 4.2% | $39.20m | |
| ZGNX | Zogenix, Inc. | 0.86% | 46.90 | 11.9% | $38.19m | |
| HZNP | Horizon Pharma plc | -0.63% | 20.50 | 7.4% | $33.41m |
Company Profile
Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.